Artesunate ointment for anal precancer in HIV-negative adults
Treatments studied
Part of Cancer, Infections clinical trials.
This trial tests an artesunate ointment to treat high-grade anal precancer (HSIL) in people who do not have HIV. The goal is to see if the ointment can clear the abnormal cells caused by HPV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a biopsy-confirmed high-grade anal precancer (AIN 2, AIN 3, or HSIL).
- You have a positive test for anal HPV.
- You are HIV-negative.
- You are not pregnant or breastfeeding, and you (or your partner) agree to use birth control during the study if you could become pregnant.
- Your weight is at least 110 pounds (50 kg).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a probiotic called EXE-346 can help clear anal high-grade squamous intraepithelial lesions (HSIL), a precancerous condition, in people with HIV who are on effective antiretroviral therapy. If you have anal HSIL that wasn't fully removed by biopsy, you may be able to join.
This study tries to prevent anal cancer in men who have sex with men and are at higher risk due to HIV or PrEP use. It uses a special exam called high-resolution anoscopy to check for early signs.
This study tests whether a curcumin (turmeric) suppository can safely treat anal precancerous changes called AIN 2 or AIN 3. It may be an option if you have high-grade cell changes and want to avoid more invasive treatments.
This early-phase study (Phase 1) tests how safe and tolerable the medicine lopinavir/ritonavir is for adults with HIV and biopsy-confirmed high-grade anal dysplasia. It may help find a possible treatment option for people at higher risk, while also checking for side effects and whether the study plan can be followed.
This trial tests an artesunate ointment for women with high-grade vulvar lesions caused by HPV. It aims to see if the ointment can help the lesions heal or disappear without needing surgery.
This trial tests an oral medication called artesunate to see if it can help treat cervical precancer (CIN2/3) caused by HPV. It is a possible option for women who are newly diagnosed and have not had this condition before.
Hear when a new Anal HSIL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.